Delivery Order SPE2DB24D2205-SPE2DB25FEEVL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,174.80 to supply 200-unit vials of XEOMIN on April 24, 2025, with an ultimate completion date of May 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of XEOMIN 100 Unit vials with a firm fixed price ceiling value of $13,968.50 and a completion date of June 26, 2025. This non-set-aside, competitively awarded delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 21, 2025, with a ceiling value of $1,955.59 for the supply of XEOMIN 100 Unit Vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made through competitive procedures with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,117.48 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-competitive set-aside and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for 200 unit vials of XEOMIN with a ceiling value of $16,762.20. This firm fixed price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by October 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Xeomin 50 unit vials valued at $10,941.84. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with a completion date of September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of XEOMIN 100 Unit vials. This firm fixed-price delivery order, valued at $23,467.08, represents a non-competitive set-aside award and is scheduled for completion by August 7, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award is issued as a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $27,937.00 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, with a completion date of July 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XEOMIN 200 unit vials with a ceiling value of $2,234.96. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 19, 2025. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of XEOMIN 100 UT vials valued at $11,174.80. This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and was awarded through open competition without set-aside provisions. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEVLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of XEOMIN 200 unit vials, with a ceiling value of $2,234.96 and an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency and its Medical Supply Chain. The company's federal contract awards demonstrate versatility in fulfilling diverse medical supply requirements ranging from specialty medications to brand-name and generic drugs, vaccines, and medical devices. This specific delivery order for XEOMIN, a neuromodulator used in medical aesthetics and therapeutic applications, reflects AmerisourceBergen's capability to meet precise pharmaceutical procurement requirements for military and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/14/25 |